Davis Foote 10/28/25 Davis Foote 10/28/25 GLOBE NEWSWIRE: NeXtGen Biologics Successfully Completes First FDA Audit with Zero 483 Observations Read More Davis Foote 10/21/25 Davis Foote 10/21/25 EINPRESSWIRE: Axolotl-Derived NeoMatriX® Showcased in National Wound Care Conference Read More Davis Foote 10/7/25 Davis Foote 10/7/25 GLOBE NEWSWIRE: NeXtGen Biologics Announces Issuance Of A Third New Patent Covering Axolotl-Derived Technology Read More
Davis Foote 10/28/25 Davis Foote 10/28/25 GLOBE NEWSWIRE: NeXtGen Biologics Successfully Completes First FDA Audit with Zero 483 Observations Read More
Davis Foote 10/21/25 Davis Foote 10/21/25 EINPRESSWIRE: Axolotl-Derived NeoMatriX® Showcased in National Wound Care Conference Read More
Davis Foote 10/7/25 Davis Foote 10/7/25 GLOBE NEWSWIRE: NeXtGen Biologics Announces Issuance Of A Third New Patent Covering Axolotl-Derived Technology Read More
